Ying W, Martineau D, Beitz J, Lappi D A, Baird A
Department of Molecular and Cellular Growth Biology, Whittier Institute for Diabetes and Endocrinology, La Jolla, California 92037.
Cancer. 1994 Aug 1;74(3):848-53. doi: 10.1002/1097-0142(19940801)74:3<848::aid-cncr2820740310>3.0.co;2-j.
The authors attached basic fibroblast growth factor (FGF-2), a growth factor for numerous tumors and normal cell types, to saporin (SAP), a ribosome-inactivating protein isolated from the plant Saponaria officinalis. The conjugate (FGF-SAP) then was tested for antitumor activity using B16-F10 melanoma cells. This rapidly growing murine melanoma cell line has been used classically as a model to screen antitumor agents.
B16-F10 cells in culture were used for in vitro experiments or introduced into C57BL/6 mice to demonstrate the in vivo antitumor activities of FGF-SAP.
FGF-SAP was found to be an extremely effective cytocidal agent in vitro with an ED50 of 30-60 pM. The effects were specific for FGF-2 receptors, as shown by the ability of FGF-2 to block FGF-SAP action. In the in vivo models, FGF-SAP was found to increase survival time, inhibit tumor growth, and decrease metastases.
The authors conclude that this mitotoxin has potent in vitro and in vivo effects on B16-F10 cells, supporting the hypothesis that ligand-mediated cytotoxicity can control tumor growth.
作者将碱性成纤维细胞生长因子(FGF - 2,一种对多种肿瘤和正常细胞类型都起作用的生长因子)与皂草素(SAP,一种从植物肥皂草中分离出的核糖体失活蛋白)相连。然后使用B16 - F10黑色素瘤细胞对该偶联物(FGF - SAP)进行抗肿瘤活性测试。这种快速生长的小鼠黑色素瘤细胞系一直被经典地用作筛选抗肿瘤药物的模型。
培养的B16 - F10细胞用于体外实验,或接种到C57BL / 6小鼠体内以证明FGF - SAP的体内抗肿瘤活性。
发现FGF - SAP在体外是一种极其有效的杀细胞剂,半数有效剂量(ED50)为30 - 60皮摩尔。如FGF - 2能够阻断FGF - SAP的作用所示,其作用对FGF - 2受体具有特异性。在体内模型中,发现FGF - SAP可延长生存时间、抑制肿瘤生长并减少转移。
作者得出结论,这种促细胞分裂毒素对B16 - F10细胞具有强大的体外和体内作用,支持了配体介导的细胞毒性可控制肿瘤生长这一假说。